NuPathe, Inc.
Biotechnology

NuPathe Inc. is a specialty pharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders. NuPathe's lead product, NuPathe's lead product, Zecuity (sumatriptan iontophoretic transdermal system), has been ... more approved by the FDA for the acute treatment of migraine with or without aura in adults. In addition to Zecuity, NuPathe has two proprietary product candidates in preclinical development: NP201 for the continuous symptomatic treatment of Parkinson's disease, which the company seeks a partner, and NP202 for the long-term treatment of schizophrenia and bipolar disorder.less

Cautionary Note Regarding Forward-Looking Statements This Site contains “forward-looking state... more